Data / Drug companies / Sandoz Inc
Sandoz Inc: 18 products in the FDA NDC directory, labeler code 0185
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sandoz Inc (labeler code 0185) lists 18 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 18 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 17, 2015.
The request: Watch Sandoz Inc (FDA labeler code 0185): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0185
- Products in commercial distribution
- 18
- Packages
- 27
- Finished drugs by generic name
- 6
- Prescription products
- 18
- Over the counter products
- 0
- Controlled substance products
- Schedule II 4
- Flagged as original packager
- 18 of 18 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- December 14, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 18 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 18 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Benazepril hydrochloride and hydrochlorothiazide | 4 | 7 |
| Metolazone | 3 | 22 |
| Bumetanide | 3 | 42 |
| Hydroxyzine pamoate | 2 | 30 |
| Orphenadrine citrate | 1 | 18 |
| Nitrofurantoin (monohydrate/macrocrystals) | 1 | 25 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 10 | 55.6% |
| Tablet, film coated | 4 | 22.2% |
| Capsule | 3 | 16.7% |
| Tablet, extended release | 1 | 5.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Central Nervous System Stimulant | 4 |
| Angiotensin Converting Enzyme Inhibitor | 4 |
| Thiazide Diuretic | 4 |
| Thiazide-like Diuretic | 3 |
| Loop Diuretic | 3 |
| Antihistamine | 2 |
| Muscle Relaxant | 1 |
| Nitrofuran Antibacterial | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Benazepril Hydrochloride and Hydrochlorothiazide | 0185-0236 | Tablet, film coated | Generic drugs (ANDA) | March 17, 2015 |
| Benazepril Hydrochloride and Hydrochlorothiazide | 0185-0325 | Tablet, film coated | Generic drugs (ANDA) | April 4, 2014 |
| Nitrofurantoin (monohydrate/macrocrystals) | 0185-0122 | Capsule | Generic drugs (ANDA) | April 6, 2005 |
| Benazepril Hydrochloride and Hydrochlorothiazide | 0185-0277 | Tablet, film coated | Generic drugs (ANDA) | February 11, 2004 |
| Benazepril Hydrochloride and Hydrochlorothiazide | 0185-0211 | Tablet, film coated | Generic drugs (ANDA) | February 11, 2004 |
| Metolazone | 0185-5600 | Tablet | Generic drugs (ANDA) | December 19, 2003 |
| Metolazone | 0185-5050 | Tablet | Generic drugs (ANDA) | December 19, 2003 |
| Metolazone | 0185-0055 | Tablet | Generic drugs (ANDA) | December 19, 2003 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0185-2099 | Tablet | Generic drugs (ANDA) | June 14, 2002 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0185-2098 | Tablet | Generic drugs (ANDA) | June 14, 2002 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0185-0853 | Tablet | Generic drugs (ANDA) | June 14, 2002 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0185-0842 | Tablet | Generic drugs (ANDA) | June 14, 2002 |
| Orphenadrine Citrate | 0185-0022 | Tablet, extended release | Generic drugs (ANDA) | February 15, 2000 |
| Bumetanide | 0185-0130 | Tablet | Generic drugs (ANDA) | November 21, 1996 |
| Bumetanide | 0185-0129 | Tablet | Generic drugs (ANDA) | November 21, 1996 |
| Bumetanide | 0185-0128 | Tablet | Generic drugs (ANDA) | November 21, 1996 |
| Hydroxyzine pamoate | 0185-0676 | Capsule | Generic drugs (ANDA) | December 14, 1981 |
| Hydroxyzine pamoate | 0185-0674 | Capsule | Generic drugs (ANDA) | December 14, 1981 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.